Latest Stock Split Details
Key information about Immune Therapeutics, Inc.'s most recent stock split
Split Date: 2021-05-06
Split Ratio: 1:1000
Price Before Split: $0.01
Price After Split: $0.00
Impact of the Stock Split
Understanding what this means for shareholders
- The total value of your investment remains the same
- You now own 1000.00 times fewer shares (a 1:1000 ratio)
- The price per share is increased proportionally
Historical Stock Splits
A comprehensive history of Immune Therapeutics, Inc.'s stock splits
| Date | Ratio | Is Reverse Split | Price Before Split | Price After Split |
|---|---|---|---|---|
| 2021-05-06 | 1:1000 | Yes | $0.01 | $0.00 |
| 2012-02-27 | 1:1000 | Yes | $0.01 | $0.00 |
About Immune Therapeutics, Inc.
Company overview and industry information
Immune Therapeutics, Inc. (IMUN) operates in the Biotechnology industry. The recent 1-for-1000 reverse stock split is part of the company's strategy to adjust its share price and potentially meet stock exchange listing requirements.
Biotechnology
Go to Immune Therapeutics, Inc. Summary